These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7516599)

  • 1. Bovine leukemia virus induces CD5- B cell lymphoma in sheep despite temporarily increasing CD5+ B cells in asymptomatic stage.
    Murakami K; Okada K; Ikawa Y; Aida Y
    Virology; 1994 Jul; 202(1):458-65. PubMed ID: 7516599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathologic study and characterization of the phenotype of transformed cells in sheep with bovine leukemia virus-induced lymphosarcoma.
    Murakami K; Aida Y; Kageyama R; Numakunai S; Ohshima K; Okada K; Ikawa Y
    Am J Vet Res; 1994 Jan; 55(1):72-80. PubMed ID: 8141500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo survival of peripheral blood mononuclear cells in sheep induced by bovine leukemia virus (BLV) mainly occurs in CD5- B cells that express BLV.
    Takahashi M; Tajima S; Takeshima SN; Konnai S; Yin SA; Okada K; Davis WC; Aida Y
    Microbes Infect; 2004 May; 6(6):584-95. PubMed ID: 15158193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further phenotypic characterization of target cells for bovine leukemia virus experimental infection in sheep.
    Aida Y; Miyasaka M; Okada K; Onuma M; Kogure S; Suzuki M; Minoprio P; Levy D; Ikawa Y
    Am J Vet Res; 1989 Nov; 50(11):1946-51. PubMed ID: 2559634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype and ontogeny of cells carrying a tumor-associated antigen that is expressed on bovine leukemia virus-induced lymphosarcoma.
    Aida Y; Okada K; Amanuma H
    Cancer Res; 1993 Jan; 53(2):429-37. PubMed ID: 8380256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovine MHC class II DRB1 alleles associated with resistance or susceptibility to development of bovine leukemia virus-induced ovine lymphoma.
    Nagaoka Y; Kabeya H; Onuma M; Kasai N; Okada K; Aida Y
    Cancer Res; 1999 Feb; 59(4):975-81. PubMed ID: 10029093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of bovine leukemia virus (BLV) proviral load harbored by lymphocyte subpopulations in BLV-infected cattle at the subclinical stage of enzootic bovine leucosis using BLV-CoCoMo-qPCR.
    Panei CJ; Takeshima SN; Omori T; Nunoya T; Davis WC; Ishizaki H; Matoba K; Aida Y
    BMC Vet Res; 2013 May; 9():95. PubMed ID: 23641811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cells from bovine leukemia virus- (BLV) infected sheep with hematological disorders express the CD5 T cell marker.
    Letesson JJ; Mager A; Mammerickx M; Burny A; Depelchin A
    Leukemia; 1990 May; 4(5):377-9. PubMed ID: 1697010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD154 costimulated ovine primary B cells, a cell culture system that supports productive infection by bovine leukemia virus.
    Van den Broeke A; Cleuter Y; Beskorwayne T; Kerkhofs P; Szynal M; Bagnis C; Burny A; Griebel P
    J Virol; 2001 Feb; 75(3):1095-103. PubMed ID: 11152482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for bovine leukemia virus infection of peripheral blood monocytes and limited antigen expression in bovine lymphoid tissue.
    Heeney JL; Valli PJ; Jacobs RM; Valli VE
    Lab Invest; 1992 May; 66(5):608-17. PubMed ID: 1315405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of GP51 expression and persistent CD5+ B-lymphocyte expansion with lymphomagenesis in bovine leukemia virus infected sheep.
    Birkebak TA; Palmer GH; Davis WC; Knowles DP; McElwain TF
    Leukemia; 1994 Nov; 8(11):1890-9. PubMed ID: 7526091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 T lymphocyte activation in BLV-induced persistent B lymphocytosis in cattle.
    Stone DM; Norton LK; Chambers JC; Meek WJ
    Clin Immunol; 2000 Sep; 96(3):280-8. PubMed ID: 10964547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
    Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
    J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host soluble factors that regulate the synthesis of the major core protein of the bovine leukemia virus (BLV) in a naturally infected neoplastic B-cell line.
    Gutiérrez S; Ceriani C; Juliarena M; Ferrer JF
    Vet Immunol Immunopathol; 2009 Oct; 131(3-4):246-58. PubMed ID: 19497626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection.
    Mirsky ML; Olmstead CA; Da Y; Lewin HA
    J Virol; 1996 Apr; 70(4):2178-83. PubMed ID: 8642640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep.
    Debacq C; Asquith B; Kerkhofs P; Portetelle D; Burny A; Kettmann R; Willems L
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10048-53. PubMed ID: 12119390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emphasis on cell turnover in two hosts infected by bovine leukemia virus: a rationale for host susceptibility to disease.
    Florins A; Boxus M; Vandermeers F; Verlaeten O; Bouzar AB; Defoiche J; Hubaux R; Burny A; Kettmann R; Willems L
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):1-7. PubMed ID: 18513803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the blood lymphocyte population in cattle infected with the bovine leukemia virus.
    Esteban EN; Thorn RM; Ferrer JF
    Cancer Res; 1985 Jul; 45(7):3225-30. PubMed ID: 2988763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of tumor-associated antigen in bovine leukemia virus-induced lymphosarcoma.
    Aida Y; Nishino Y; Amanuma H; Murakami K; Okada K; Ikawa Y
    Leukemia; 1997 Apr; 11 Suppl 3():216-8. PubMed ID: 9209345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.